Insider · CIK 0001129246

PHILLIPS CHARLES G III

Reports to the SEC for 3 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001129246

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-12-02	NVCRNovoCure LtdS Sale	Director	SSale	−6,145 sh	$88.11	−$541K	3,359
2019-08-30	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$6.72	+$148K	31,504
2019-08-30	NVCRNovoCure LtdS Sale	Director	SSale	−8,692 sh	$90.63	−$788K	22,812
2019-08-30	NVCRNovoCure LtdS Sale	Director	SSale	−12.9K sh	$91.46	−$1.18M	9,904
2019-08-30	NVCRNovoCure LtdS Sale	Director	SSale	−400 sh	$92.10	−$36.8K	9,504
2019-08-30	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	40,607
2019-05-29	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−21.5K sh	—	—	0
2019-05-29	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$6.72	+$336K	59,504
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−47.1K sh	$52.09	−$2.45M	12,424
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−2,920 sh	$52.84	−$154K	9,504
2019-05-29	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+21.5K sh	$11.39	+$245K	31,004
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−16.3K sh	$52.09	−$850K	14,678
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−5,174 sh	$52.96	−$274K	9,504
2019-05-29	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+23.6K sh	$12.30	+$290K	33,104
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−22.2K sh	$52.08	−$1.16M	10,904
2019-05-29	NVCRNovoCure LtdS Sale	Director	SSale	−1,400 sh	$52.82	−$73.9K	9,504
2019-05-29	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	62,607
2019-05-29	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−23.6K sh	—	—	0
2019-05-22	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+6,340 sh	—	—	6,340
2019-05-22	NVCRNovoCure LtdA Award	Director	AAward	+3,359 sh	—	—	9,504
2019-05-21	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+6,145 sh	$48.87	+$300K	6,145
2019-05-21	NVCRNovoCure Ltd · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,145 sh	—	—	0
2018-05-31	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+12.3K sh	—	—	12,345
2018-05-31	NVCRNovoCure Ltd · Restricted Stock UnitA Award	Director	AAward	+6,145 sh	—	—	6,145
2018-05-25	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$6.72	+$336K	50,000
2018-05-25	NVCRNovoCure LtdS Sale	Director	SSale	−50K sh	$30.30	−$1.52M	0
2018-05-25	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	—	—	112,607
2017-05-10	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+23.6K sh	—	—	23,600
2016-05-04	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+21.5K sh	—	—	21,500
2015-10-07	NVCRNovoCure Ltd · Series I Convertible Preferred SharesC Conversion	Director	CConversion	−10.7K sh	—	—	0
2015-10-07	NVCRNovoCure LtdC Conversion	Director	CConversion	+68.4K sh	—	—	68,405
2015-10-07	NVCRNovoCure Ltd · Series F Convertible Preferred SharesC Conversion	Director	CConversion	−44.9K sh	—	—	0
2015-10-07	NVCRNovoCure Ltd · Series G Convertible Preferred SharesC Conversion	Director	CConversion	−5,333 sh	—	—	0
2015-10-07	NVCRNovoCure Ltd · Series H Convertible Preferred SharesC Conversion	Director	CConversion	−3,701 sh	—	—	0
2015-10-07	NVCRNovoCure Ltd · Series J Convertible Preferred SharesC Conversion	Director	CConversion	−3,843 sh	—	—	0
2004-08-05	CHAMPPS ENTERTAINMENT INCOptions to Purchase Common StockA Award	Director	AAward	+10K sh	—	—	10,000
2003-09-15	CHAMPPS ENTERTAINMENT INCOptions to Purchase Common StockA Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Dec 44
PHILLIPS CHARLES G III0001645113-19-000016
SEC(opens sec.gov)
Sep 34
PHILLIPS CHARLES G III0001209191-19-047959
SEC(opens sec.gov)
May 314
PHILLIPS CHARLES G III0001209191-19-033629
SEC(opens sec.gov)
May 244
PHILLIPS CHARLES G III0001209191-19-032689
SEC(opens sec.gov)

Companies

Address

C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300

MALVERN, PA, 19355